Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹346Prev. Close
₹346Turnover(Lac.)
₹946.92Day's High
₹356.3Day's Low
₹336.1552 Week's High
₹513.452 Week's Low
₹263.3Book Value
₹102.87Face Value
₹5Mkt Cap (₹ Cr.)
939.17P/E
32.59EPS
10.38Divi. Yield
0.38 Sep 2023
12:00 AM
AGM
Announcement Date: 08 Sep, 2023
16 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
30 May 2023
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 23 Sep, 2023
8 Sep 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 13.8 | 13.8 | 13.8 | 13.8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 353.89 | 314.69 | 244.61 | 164.13 |
Net Worth | 367.69 | 328.49 | 258.41 | 177.93 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 656.98 | 410 | 370.17 | 327.1 |
yoy growth (%) | 60.23 | 10.76 | 13.16 | 41.81 |
Raw materials | -377.89 | -263.23 | -242.02 | -215.28 |
As % of sales | 57.51 | 64.2 | 65.38 | 65.81 |
Employee costs | -34.54 | -28.43 | -24.61 | -21.65 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 118.81 | 32.45 | 24.16 | 22.68 |
Depreciation | -16.12 | -12.12 | -11.41 | -11.08 |
Tax paid | -35.71 | -9.95 | -7.85 | -7.49 |
Working capital | 78.78 | 14.98 | 9.66 | 26.86 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.23 | 10.76 | 13.16 | 41.81 |
Op profit growth | 184.93 | 12.24 | 8.66 | 27.97 |
EBIT growth | 226.77 | 20.85 | 6.55 | 39.23 |
Net profit growth | 269.37 | 37.94 | 7.4 | 94.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,526.8 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,592 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,486 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,112.2 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,440 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjankumar R Bajaj
Joint Managing Director
Anil C Jain
Whole-time Director
Namrata S Bajaj
Whole-time Director
Dhananjay S Halte
Independent Director
Ram B Banarase
Independent Director
Hemant R Karnik
Company Sec. & Compli. Officer
Aakashkumar Kesari
Independent Director
Loukik D Tipnis
Independent Director
Kejal Shah
Whole-time Director
Pakshal Jain
Whole Time Director
Rupesh H Nikam
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Bajaj Healthcare Ltd
Summary
Bajaj Healthcare Ltd. is a bulk drug manufacturer established in 1993, serving various Pharmaceuticals, Nutraceuticals and Food industries globally with a spirit of scrupulousness. The Company commenced its operations in 1993 with a single unit at Tarapur. It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra. It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities. In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility. In 2013, it set up another API and Intermediate manufacturing plant at Panoli, Ankleshwar and acquired and set up an Intermediate Unit in Tarapur MIDC, near Mumbai in November, 2014.In FY 2019-20, the Company acquired Intermediates manufacturing Unit at MIDC, Tarapur Maharashtra and also agreed to acquire Four Manufacturing facilities, comprising of three APIs manufacturing facilities, one Engineering Unit, at MIDC Tarapur, Maharashtra along with an Industrial Plot at Dahej, Gujarat.The Company started commercial operations at Panoli Unit, in Bharuch from May 11, 2022. In 2021-22, it launched a Nutraceutical named Magnesium L-Threonate; commenced commercial production at Tarapur, for Nimesulide API, used for relief from pain and prevention of fe
Read More
What is the Bajaj Healthcare Ltd share price today?
The Bajaj Healthcare Ltd shares price on nse is Rs.₹340.3 today.
What is the Market Cap of Bajaj Healthcare Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bajaj Healthcare Ltd is ₹939.17 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Bajaj Healthcare Ltd?
The PE and PB ratios of Bajaj Healthcare Ltd is 32.59 and 3.35 as of 03 Jul ‘24
What is the 52 Week High and Low of Bajaj Healthcare Ltd?
The 52-week high/low is the highest and lowest price at which a Bajaj Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bajaj Healthcare Ltd is ₹263.3 and ₹513.4 as of 03 Jul ‘24
What is the CAGR of Bajaj Healthcare Ltd?
Bajaj Healthcare Ltd's CAGR for 5 Years at N/I%, 3 Years at -1.58%, 1 Year at 9.91%, 6 Month at -7.52%, 3 Month at 12.08% and 1 Month at 21.15%.
What is the shareholding pattern of Bajaj Healthcare Ltd?
The shareholding pattern of Bajaj Healthcare Ltd is as follows:
Promoters - 67.73 %
Institutions - 0.96 %
Public - 31.30 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
